These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe insulin resistance treated with insulin lispro. Gill G; Williams G Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571 [No Abstract] [Full Text] [Related]
3. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps. Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330 [No Abstract] [Full Text] [Related]
4. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report. Lahtela JT; Knip M; Paul R; Antonen J; Salmi J Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697 [TBL] [Abstract][Full Text] [Related]
5. Cannula occlusion with use of insulin lispro and insulin infusion system. Wright AW; Little JA Diabetes Care; 1998 May; 21(5):874-5. PubMed ID: 9589263 [No Abstract] [Full Text] [Related]
7. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin. Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086 [No Abstract] [Full Text] [Related]
8. Metabolic decompensation in pump users due to lispro insulin precipitation. Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980 [No Abstract] [Full Text] [Related]
9. [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)]. Awa T; Nakata T; Shigeta H Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):143-51. PubMed ID: 16205018 [No Abstract] [Full Text] [Related]
16. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients. Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707 [No Abstract] [Full Text] [Related]
17. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Attia N; Jones TW; Holcombe J; Tamborlane WV Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247 [TBL] [Abstract][Full Text] [Related]
18. Insulin confusion: an observation. Phillips W; Lando H Diabetes Care; 2002 Jun; 25(6):1103-4. PubMed ID: 12032129 [No Abstract] [Full Text] [Related]
19. Lispro insulin: adsorption and stability in selected intravenous devices. Ling J; Hu M; Hagerup T; Campbell RK Diabetes Educ; 1999; 25(2):237-45. PubMed ID: 10531849 [TBL] [Abstract][Full Text] [Related]